Viewing Study NCT06060704


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:06 PM
Study NCT ID: NCT06060704
Status: UNKNOWN
Last Update Posted: 2023-10-11
First Post: 2023-09-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module